Comparison of alendronate and raloxifene for treatment of postmenopausal osteoporosis: Results from EFFECT and EFFECT-international

被引：0
|
作者：
Kagan, R
Sambrook, P
Luckey, M
Geusens, P
de Papp, A
Melton, ME
机构：
[1] Fdn Osteoporosis Res & Educ, Oakland, CA USA
[2] Univ Sydney, Sydney, NSW 2006, Australia
[3] St Barnabas Osteoporosis & Metab Bone Dis Ctr, Livingston, NJ 07039 USA
[4] Maastricht Univ, Maastricht, Netherlands
[5] Merck & Co Inc, Whitehouse Stn, NJ USA
来源：
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY | 2003年 / 10卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：596 / 596
页数：1
相关论文
共 50 条
  • [1] Greater increases in bone mineral density with alendronate compared to raloxifene: Results from effect-international
    Geusens, P
    Sambrook, P
    Ferrer-Barriendos, J
    Ribot, C
    Solimano, JA
    Verbruggen, N
    Gaines, K
    Melton, ME
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S47 - S47
  • [2] Comparison of alendronate and raloxifene in postmenopausal women with osteoporosis
    Sanad, Z.
    Ellakwa, H.
    Desouky, B.
    CLIMACTERIC, 2011, 14 (03) : 369 - 377
  • [3] The effect of raloxifene after discontinuation of long-term alendronate treatment of postmenopausal osteoporosis
    Michalská, D
    Stepan, JJ
    Basson, BR
    Pavo, I
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2006, 91 (03): : 870 - 877
  • [4] Effect of alendronate in postmenopausal women with systemic osteoporosis treatment
    Povoroznyuk, Vladyslav V.
    Orlyk, Tatyana V.
    Dzerovych, Nataliya I.
    BONE, 2008, 42 : S83 - S84
  • [5] Comparison of raloxifene and alendronate on markers of cardiovascular health in postmenopausal women with osteoporosis
    Reginster, JY
    Adachi, JR
    Qu, Y
    Siddhanti, S
    Keech, C
    OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S42 - S42
  • [6] Patient compliance with alendronate, risedronate and raloxifene for the treatment of osteoporosis in postmenopausal women
    Ringe, J. D.
    Christodoulakos, G. E.
    Mellstroem, D.
    Petto, H.
    Nickelsen, T.
    Marin, F.
    Pavo, I.
    CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (11) : 2677 - 2687
  • [7] Effect of raloxifene after teriparatide treatment in postmenopausal women with osteoporosis
    Adami, S.
    Munoz-Torres, M.
    Econs, M. J.
    Sipos, A.
    Xie, L.
    Dalsky, G. P.
    McClung, M.
    Felsenberg, D.
    Brown, J. P.
    Brandi, M. L.
    San Martin, J.
    OSTEOPOROSIS INTERNATIONAL, 2006, 17 : S137 - S137
  • [8] Individualizing therapy to prevent postmenopausal osteoporosis: A comparison of hormone therapy, alendronate, and raloxifene
    Col, NF
    Pauker, SG
    Goldberg, RJ
    Eckman, MH
    Orr, RK
    Ross, EM
    Wong, JB
    MEDICAL DECISION MAKING, 1998, 18 (04) : 467 - 467
  • [9] Greater increases in BMD with alendronate compared to raloxifene: Results from EFFECT-International.
    Sambrook, P
    Geusens, P
    Ferrer-Barriendos, J
    Ribot, C
    Solimano, JA
    Verbruggen, N
    Gaines, K
    Melton, ME
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S90 - S90
  • [10] Comparison of raloxifene and alendronate on markers of cardiovascular health in postmenopausal women with osteoporosis.
    Adachi, JD
    Reginster, J
    Qu, Y
    Siddhanti, S
    Keech, C
    JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 : S379 - S379
12345